Compugen Reports First Quarter 2021 Results

Go back to Compugen Reports First Quarter 2021 Results

Compugen (CGEN) Tops Q1 EPS by 1c

May 13, 2021 7:16 AM EDT

Compugen (NASDAQ: CGEN) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

"2021 will be an important year of milestones and execution for Compugen," said Anat Cohen-Dayag, Ph.D., President and CEO of Compugen. "During this year we expect to share data readouts for COM701 in monotherapy, dual and triple combination studies, as well as our... More